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ABSTRACT 
Exosomes show promise as non-invasive biomarkers for cancers, but their effective 
capture and specific detection is a significant challenge. Herein, we report a 
multiplexed microfluidic device for highly specific capture and detection of multiple 
exosome targets using a tunable alternating current electrohydrodynamic (ac-EHD) 
methodology - referred to as nanoshearing. In our system, electrical body forces 
generated by ac-EHD act within nanometers of an electrode surface (i.e., within the 
electrical layer) to generate nanoscaled fluid flow which enhances the specificity of 
capture and also reduce nonspecific adsorption of weakly bound molecules from the 
electrode surface. This approach demonstrates the analysis of exosomes derived from 
cells expressing human epidermal growth factor receptor 2 (HER2) and prostate 
specific antigen (PSA), and also capable of specifically isolating exosomes from 
breast cancer patient samples. The device also exhibited a 3-fold enhancement in 
detection sensitivity in comparison to hydrodynamic flow based assays (LOD 2750 
exosomes/µL for ac-EHD vs LOD 8300 exosomes/µL for hydrodynamic flow; (n = 
3)). We believe this approach can potentially find its relevance as a simple and rapid 
quantification tool to analyze exosome targets in biological applications. 
KEYWORDS  
AC electrohydrodynamics, exosomes, multiplex detection, microfluidic devices 
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INTRODUCTION 
Exosomes are membrane nanovesicles released from cells and are present in body 
fluids such as blood, urine and saliva.
1
 They are believed to carry a cargo of proteins, lipids, 
mRNA, microRNA (miRNA) and transfer this cargo to recipient cells which alter the 
biochemical composition, signalling pathways, and genomic states of the recipient cells.
2,3  
This could also enable them to engage in multiple cell-receptor (surface) interactions 
simultaneously. Exosomes can thus serve as extracellular messengers mediating cell-cell 
communication, raising the possibility of these enveloped exosomal receptors in body fluids 
as novel non-invasive biomarkers for cancer.
3,4
 Although  their physiological roles are still 
under investigation there is a growing need for reliable methods for accurate isolation and 
detection of exosomes from biological fluids. Current methods for the isolation and 
characterisation of exosomes (e.g., ultracentrifugation, electron microscopy etc.) cannot 
discriminate between exosomes and other membrane vesicles, lipid structures, or retrovirus 
particles found in body fluids which are similar in terms of size and density.
4-6
 More recently, 
several microfluidic approaches
7-9
 using laminar flow based fluid micromixing have been 
reported to specifically isolate exosomes from biological fluids. Despite their excellent 
demonstrations, they are limited by their inability to manipulate surface shear forces to 
reduce nonspecific adsorption of cells or other molecules and provide quantitative 
information on these isolated nanovesicles. Therefore, a methodology that can effectively 
isolate and specifically detect these vesicles and their enveloped biomarkers in complex 
biological samples could provide further insights into the fundamental role and functions of 
these poorly understood, yet highly important biological vesicles.  
Herein, we present a simple, multiplexed microfluidic platform to address these 
problems in current exosome detection methodologies. Our approach relies on the use of an 
alternating current (ac) electrohydrodynamic (ac-EHD) induced surface shear force which 
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engenders lateral fluid flow within few nanometers of an electrode surface.
10-14  
Because this 
phenomenon
 
involves a shear force within a few nanometers of the surface, we refer to it as 
nanoshearing. When samples containing target exosomes are driven through antibody-
functionalized devices under ac-EHD flow (Figure 1), it provides the capability to 
specifically capture these exosomes by increasing the number of exosome-antibody (surface 
bound) collisions, which is a result of improved analyte transport. Since the magnitude of this 
force can be tuned externally via the application of frequency and/or amplitude, it can be 
applied to preferentially select specifically bound exosomes over nonspecifically adsorbed 
non-target species to surfaces (i.e., non-target species bound weakly to the surface than that 
of the specifically captured exosomes). This method also provides the capability to 
simultaneously detect multiple exosome targets using a simple and rapid on-chip naked eye 
detection readout (i.e., avoids use of any sophisticated instrumental readouts) based on the 
catalytic oxidation of peroxidase (e.g., from horseradish peroxidise (HRP) conjugated 
detection antibody) substrate 3,3',5,5'-Tetramethylbenzidine (TMB).
15 
Additionally, UV-
Visible spectroscopy measurements from the colorimetric solutions provide quantitative 
analysis of multiple exosomes in a single assay format. The performance of our device for 
spiked exosome and patient serum samples was comparable with current exosome isolation 
and detection technologies. 
 
 
EXPERIMENTAL SECTION 
Reagents. Unless stated otherwise, general-use reagents were purchased from Sigma Aldrich 
(Australia) and immunoassay reagents were obtained from R&D/Life Technologies 
(Burlington, ON), Thermo-Fisher Scientific (Australia), Abcam (Australia) and Invitrogen 
(Australia). All reagents and washing solutions used in the experiments were prepared using 
phosphate buffer saline (PBS, 10 mM, pH 7.4).  Stock solutions of antibody were diluted in 
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PBS. Photoresists for fabrication (Microchem, CA) were used as per manufacturer’s 
instructions. 
Design of Multiplexed ac-EHD Devices. In this study, we designed a multiplexed 
microfluidic device containing asymmetric planar microelectrode pairs within a long 
microchannel. The device contains three channels with individual inlet and outlet ports with 
each channel comprising of 50 asymmetric planar electrode pairs (Figure S1, Supporting 
Information). The small electrode of 50 μm and large electrode of 250 μm are separated by a 
distance of 50 µm. Adjacent electrode pairs in each segment are separated by a distance of 
150 μm.  The narrow and wide electrodes of each asymmetric electrode pair in all three 
channels are connected to individual gold connecting pads (Figure S1, Supporting 
Information) that form the cathode and anode respectively. The critical gap (r0) between 
small (d1) and large electrodes (d2) in each pair and the distance between adjacent electrode 
pairs (r1) in the array influence the ac-EHD induced fluid flow and the associated 
micromixing. Previously, Brown et al.
16
 and Ramos et al.
 17
 have demonstrated that the fluid 
flow rate is inversely proportional to the geometry of the electrodes. The asymmetry in 
electrode geometry in our device was optimized to engender effective ac-EHD induced fluid 
flow (i.e., acts as a fluid pump) and micromixing within the channel, and was maintained 
uniformly throughout each channel as: r0/d2 = 0.2, r1/d2 = 0.6, d1/d2 = 0.2, respectively. The 
device design was made using Layout Editor (L-edit V15, Tanner research Inc., CA) and 
written to a chrome mask (5” X 5”; Qingyi Precision Mask-making (Shenzhen) Ltd, China).   
 
Fabrication of Devices. Devices were fabricated at the Queensland node of Australian 
National Fabrication Facility (Q-ANFF node). Fabrication of the device involves a two-step 
standard photolithographic process as outlined in Figure S2, Supporting Information.  
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a. Fabrication of asymmetric gold electrode patterns. Initially, a passivation layer of silicon 
dioxide (thickness- 300 nm) was deposited on silicon wafers (diameter- 100 mm; thickness-1 
mm; single-side polished) in an oxidation furnace. The wafers were then cleaned with 
sonication in acetone for 5 min, rinsed with isopropyl alcohol and water for another 2 min, 
and dried with the flow of nitrogen. A thin film of negative photoresist (AZnLOF 2070, 
Microchem, Newton, MA) was spin coated (3000 rpm for 30 s) onto the wafer and soft baked 
at 110 ºC for 6 min. Subsequent UV exposure (280 mJ/cm
2
) using a mask aligner (EVG 620, 
EV Group GmbH, Austria) and development (AZ 726 developer for 3 min) revealed the 
exposed patterns without photoresist. Metallic layers of Ti (10 nm) and Au (200 nm) were 
deposited using an electron beam (e-beam) evaporator (Temescal FC-2000) under high 
vacuum conditions followed by lift-off using ethanol revealed the patterned gold electrodes. 
The wafers were then diced (ADT 7100 wafer precision dicer) to obtain individual devices. 
Devices were characterized by SEM analysis using a JEOL (model 6610) instrument 
operating at an accelerating voltage of 10 kV.  
b. Fabrication of Microfluidic Channels. The fabrication of microfluidic channels (Figure 
S2, Supporting Information) involve a two-step process that include the (i) fabrication of an 
SU-8 master molds containing three independent microfluidic channels (width, w = 400 μm; 
height, h = 300 μm; length, l = 25 mm) with 1 mm diameter inlet and outlet ports, and (ii) 
fabrication of microfluidic channels on PDMS using the master molds. Initially, a layer of 
negative photoresist (SU-8 2150; MicroChem, MA) was spin coated (1800 rpm) onto a clean 
silicon wafer (diameter, 100 mm; thickness-1 mm; single-side polished). The wafer was soft 
baked through a series of step change in temperature (65 °C for 7 min, 95 °C for 60 min, 65 
°C for 5 min). Subsequent UV exposure (380 mJ/cm
2
) was followed by a post-bake step 
(from 65 °C for 5 min, 95 °C for 20 min, 65 °C for 3 min). To reveal the fluidic channels the 
wafers were developed in propylene glycol methyl ether acetate (PGMEA) for 45 min. These 
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SU-8 masters were then used as molds, on which polydimethylsiloxane (PDMS) prepolymer 
mixed with its crosslinker (ratio 10:1; Sylgard 184 kit, Dow Corning) was poured, degassed, 
and allowed to cure in a conventional oven at 65 ºC for 2 h. The cured PDMS replicas were 
removed from the molds and 1 mm holes were punched into PDMS at either ends of the 
channel to define the inlet and outlet ports (diameter, 1 mm).  
 
Cell Culture and Isolation of Exosomes. Breast cancer (HER2(+): BT-474; HER2(-): 
MDA-MB-231) and prostate cancer (PSA(+): PC3) cell lines were maintained in 
microvesicles depleted serum free Media 171 (Gibco, UK) supplemented with Mammary 
Epithelial supplement (Gibco, UK), 1% Pencillin/streptomycin and grown in 5% CO2 at 37 
o
C.  The conditioned medium from 10
6
 cells was collected after 60 h and centrifuged at 2000 
× g for 30 min to eliminate cell contamination (e.g., cells and debris). Exosomes were 
isolated using Total Exosome isolation reagent (Life Technologies) as per manufacturer’s 
instructions. Briefly, the supernatant was transferred to a new tube and the isolation reagent 
was added to the tube in the ratio 2:1. The samples were incubated overnight at 4 
o
C followed 
by filtration using 0.22 µm filter and centrifugation at 10000 × g for 1 h to obtain exosome 
pellets. Exosome pellets were then resuspended in 100 µL PBS (10 mM, pH 7.0) and stored 
at -20 
o
C for further use.  
 
Cryo-Transmission Electron Microscopy (Cryo-TEM). For cryo-TEM, 4 µL of exosome 
preparations were directly adsorbed onto lacey carbon grids (Quantifoil, Germany) and 
plunged into liquid ethane, using an FEI Vitrobot Mark 3 (FEI Company, The Netherlands). 
Grids were blotted at 100% humidity at 4 ºC for about 3-4 s. Frozen/vitrified samples were 
imaged using Tecnai T12 Transmission Electron Microscope (FEI Company) operating at an 
acceleration voltage of 120 kV. Images were taken at 30,000x magnification, (approximate 
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dose of 13.6 electrons/Å
2
), using an FEI Eagle 4k CCD (FEI Company), and SerialEM image 
acquisition software. 
 
Dynamic Light Scattering Analysis. Exosome samples were prepared by spiking 1 µL of 
isolated exosomes in PBS (10 mM, pH 7.0) to obtain the desired dilution (1:1000). The size 
and zeta potentials of the nanovesicles were measured using a dynamic laser scattering (DLS) 
instrument (Zetasizer 3000HSA, Malvern Instrument) at 25 
o
C under a refractive index of 
1.33 and viscosity of 0.89 mPa.s .  
 
Device functionalization. Prior to functionalization, the electrodes were cleaned by 
sonication in acetone for 5 min, rinsed with isopropyl alcohol and water for another 2 min, 
and dried with the flow of nitrogen. The array of gold microelectrode pairs within the capture 
domain of the channel were then modified with the capture antibody (e.g., anti-HER2, anti-
CD9 and/or anti-PSA) using avidin-biotin chemistry (Figure 2) in a three step process. 
Initially, devices were incubated in biotinylated BSA (200 μg/mL in PBS, Invitrogen) 
solution for 2 h followed by coupling with streptavidin (100 μg/mL in PBS, Invitrogen) for 1 
h at 37 
o
C. Streptavidin conjugated channels were then coated with biotinylated capture 
antibody (e.g., anti-HER2 and/or anti-PSA or anti-CD9; 10 μg/mL in PBS, R&D systems) for 
another 2 h. Channel was flushed three times with PBS (10 mM, pH 7.0) to remove any 
unbound molecules after each step. Each of the surface modification steps (e.g., biotinylated 
BSA, streptavidin, and capture antibody) was performed manually by filling the 
microchannel with corresponding solution to specifically modify the array of gold electrodes 
within the capture domain. PDMS containing the microchannels was then aligned manually 
onto the electrodes and sandwiched between custom built device holders (Figure S3, 
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Supporting Information) for samples to be filled and withdrawn via inlet and outlet ports, 
respectively. 
 
Exosome capture and detection. The concentration of exosomes in the isolated pellets was 
obtained using qNano measurements performed as described previously.
18
 Exosome samples 
were prepared by spiking 1 µL of isolated exosomes in PBS (10 mM, pH 7.0) to obtain the 
desired dilution (1:1000). Concentration measurements were obtained by calibrating particle 
count rate recordings against a reference particle suspension (polystyrene beads, d = 115 nm). 
Samples were then prepared by spiking designated volumes of isolated exosomes in PBS (1 
mM, pH 7.0) to obtain the desired sample dilutions (1:200 to 1:3000) in a given volume            
(500 µL). Serum samples (1 mL) of two breast cancer patients were obtained from Ventyx 
Wesley Research Institute Tissue Bank, Brisbane, Australia and stored in -80 
o
C until further 
use. Immunohistochemical expression analysis suggested overexpression (3+: Patient A) and 
very low expression (1+; Patient B) of HER2 in these patient samples. The small and large 
electrodes within the long channel of the ac-EHD devices (Figure S1,S3, Supporting 
Information) were connected to a signal generator (Agilent 33220A Function Generator, 
Agilent Technologies, Inc., CA) via gold connecting pads. Samples were then placed in the 
inlet reservoirs of the devices and driven through the channel by applying ac-EHD field. The 
field strength was applied for 30 min with 15 min intervals (without fluid flow) for a total 
pumping time of approximately 2 h. Control experiments were performed in the absence of 
ac-EHD field under pressure driven flow conditions using a syringe pump (PHD 2000, 
Harvard apparatus). Detection antibody FITC conjugated anti-HER2 (2 μg/mL; Invitrogen, 
UK) was driven through the channels under ac-EHD and/or pressure driven flow conditions. 
For anti-PSA and/or anti-CD9 functionalized devices, the detection antibody HRP conjugated 
anti-PSA (2 μg/mL; abcam) and/or FITC conjugated anti-CD9 (2 μg/mL; abcam) was driven 
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through the channels under ac-EHD fluid flow. anti-HER2 functionalized devices were 
imaged under a fluorescence microscope (Nikon eclipse Ni-U upright microscope) to obtain 
fluorescence images of the captured exosomes. anti-HER2 and/or anti-CD9 functionalized 
devices were then further incubated with anti-fluorescein HRP (1:1000; abcam) antibody for 
45 min. Channels were flushed three times with PBS (1 mM, pH 7.0) after subsequent steps 
to remove any unbound molecules. 80 µL of 3,3',5,5'-tetramethylbenzidine (TMB) solution 
was driven though the channels manually and the colorimetric reaction was allowed to 
proceed for 5 min to facilitate naked eye detection from the resulting colour change in 
solution. The colorimetric solution was withdrawn manually from the device using a 
micropipette and collected in an eppendorf for subsequent absorbance measurements. 
Absorbance measurements were obtained using a UV-Visible spectrophotometer (Shimadzu 
UV-2450, Shimadzu Corp.) and absorbance data was acquired using UVProbe (Ver. 2.3.1) 
data acquisition software.  
 
RESULTS AND DISCUSSION 
To investigate the applicability of nanoshearing phenomenon, we constructed a 
multiplexed microfluidic device (see Experimental for design and fabrication details; Figure 
3a,b and Figure S1,S2, Supporting Information) with three independent microchannels 
comprehending a long array of consecutively placed asymmetric electrode pairs within each 
channel. The device was sandwiched between custom built holders with the small and large 
electrodes within the long channel being connected to a signal generator (see Figure S3, 
Supporting Information for experimental setup). The application of an alternating potential 
difference to each pair of asymmetric electrodes results in a nonuniform electric field E 
(Figure 1) that induces charges in the double layer  (D  = Debye length). The lateral variation 
in the total amount of induced double layer charges and spatial distribution of charges on the 
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electrode surface give rise to stronger lateral forces on the large electrode, resulting in fluid 
flow towards the large electrode.
10,16
 This lateral flow due to surface shear forces generated 
within nanometers (D = ~ 4 nm, calculated for 1 mM phosphate buffer saline (PBS) using 
Debye-Huckel approximation
19
 and use of the equation described in ref.11) of an electrode 
surface is unidirectional. This unidirectional flow causes analytes in solution to be dragged by 
the flow, and their interaction with the surface is significantly enhanced (Figure 1).  
To demonstrate the utility of nanoshearing effect for exosome detection, we tested the 
capture and detection of exosomes obtained from breast cancer cell lines expressing human 
epidermal growth factor receptor 2 (HER2), an important breast cancer therapeutic target.
20
 
Exosomes were isolated (see Experimental for exosome isolation) from breast cancer cell line 
BT-474 showing HER2 overexpression.
21
 Western blotting analysis verified the HER2 
expression in these BT-474 derived exosomes (data not shown). Characterization of the 
isolated exosomes using cryo-Transmission Electron Microscopy (TEM) suggested that 
predominantly these vesicles contained double-walled lipid membrane layers (Figure 3c). 
Dynamic Light Scattering (DLS) measurements (Figure 3d) suggested that the large 
population of exosomes (e.g., 98±0.7%) falling within the size range of 30-350 nm with the 
average vesicle size determined to be 111±3.07 nm. The morphological and physical 
characteristics determined using these techniques corroborate with previous evidences
22,23
 
suggesting that these nanovesicles are probably of exosomal origin and were used for further 
capture experiments using multiplexed ac-EHD devices.     
 The critical determinants that comprehend the tuning capability of surface shear 
forces and concomitant micromixing include the ac frequency and amplitude. To determine 
the optimal ac-EHD induced forces for exosome capture, the electrode surface on individual 
channels of the device was initially functionalized (see Experimental and Figure 2 for 
exosome capture and detection) with anti-HER2 capture antibody. Samples containing 
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isolated exosomes (1:200 in PBS; see Experimental for sample preparation) were driven 
through the devices under the frequency (f) range of 600 Hz-100 kHz at constant amplitude 
(Vpp) of 100 mV. The captured exosomes were detected via a rapid (~5 min) on-chip naked 
eye read-out obtained due to the oxidation of TMB.
 
The colorimetric solution was collected 
manually from the device and the corresponding absorbance measurements using UV-visible 
spectroscopy measurements (maximum absorbance at 652 nm; A652nm) provided quantitative 
information on the captured exosomes. Figure 4a,b demonstrates spiked exosome samples 
under the frequency range of 600 Hz -100 kHz at Vpp = 100 mV. Capture performance of the 
device was found to be a function of the applied frequency as observed from the initial sharp 
colour change to deep blue (600 Hz and1 kHz in Figure 4a) and a gradual change in colour to 
a clear solution (1 kHz- 100 kHz in Figure 4a) with increase in frequency. UV-Visible 
spectroscopy measurements (Figure 4b, inset) and absorbance peak at 652 nm (A652nm; Figure 
4b) also demonstrated a similar trend in capture levels thereby further verifying these 
observations. The resulting higher level of capture at low field (e.g., f = 1 kHz and Vpp = 100 
mV) is probably due to the effective stimulation of the fluid flow around the capture domain 
that can maximize the effective exosome-antibody collisions (a condition where shear force < 
antibody-exosome binding force). In contrast, at higher frequencies the ac-EHD forces (e.g., f 
= 100 kHz, Vpp = 100 mV) result in stronger fluid flow which could ablate exosome 
recognition (a condition where shear forces > antibody-antigen affinity interaction) and 
decrease the capture level. Therefore, the ac-EHD force resulted from the frequency of 1 kHz 
and amplitude of 100 mV was used for further studies in demonstrating the application of ac-
EHD induced nanoshearing phenomenon in detecting exosomes.  
To validate the specificity and accuracy of exosome capture and detection, control 
experiments were performed under applied ac-EHD field strength of f = 1 kHz and Vpp= 100 
mV using samples spiked with (1:200 in PBS) and without exosomes. In the case of samples 
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without exosomes, negligible nonspecific binding of the FITC conjugated detection antibody 
was observed under ac-EHD field as evident from the absorption spectra (red; Figure S4a, 
Supporting Information). Representative fluorescence images (see Experimental for details) 
of the detected exosomes and nonspecifically bound detection antibody are shown in Figure 
S4b,c, Supporting Information. To further investigate the specificity of detection, we 
performed additional control experiments using (i) devices functionalized without anti-HER2 
capture antibody and (ii) devices without FITC conjugated anti-HER2 detection antibody. 
Samples containing spiked exosomes (1:200 in PBS) were driven through the devices under 
the applied ac-EHD flow conditions (f = 1 kHz and Vpp= 100 mV). As can be seen in                      
Figure S5a,b, Supporting Information, devices without capture (blue; Figure S5a, Supporting 
Information) and/or detection antibody (green; Figure S5b, Supporting Information) did not 
have a substantial effect in altering detection capabilities of the devices owing to negligible 
nonspecific binding of the detection antibody (e.g., device without capture antibody) and the 
absence of HRP for TMB oxidation (e.g., device without detection antibody) respectively. 
This data suggests that ac-EHD induced nanoshearing can facilitate specific capture of target 
exosomes by minimising background response from detection antibody.  
Tetraspanin superfamily proteins (e.g., CD9, CD63, CD81, CD82 etc.) are one of the 
most abundant protein markers found in exosomes isolated from virtually any cell type.
1
 To 
investigate the selectivity of capture and detection, we performed capture experiments on 
anti-CD9 functionalized devices using exosomes isolated from HER2(+) BT-474 and  
HER2(-) MDA-MB-231 breast cancer cell lines. Figure S5c, Supporting Information, 
demonstrates capture performance of the device for spiked samples containing exosomes 
(1:200 in PBS) isolated from BT-474 and MDA-MB-231 cell lines. Under the applied field 
strength (f = 1 kHz and Vpp= 100 mV), the capture performance was found to be almost 
similar for exosome samples isolated from both BT-474 (black, Figure S5c, Supporting 
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Information) and MDA-MB-231 (red; Figure S5c, Supporting Information) cell lines. These 
results support the fact that our approach is highly selective considering the specific capture 
of exosomes derived from HER2(+) and HER2(-) cell lines using anti-CD9 functionalized 
devices. To further verify the selectivity and specificity of our approach, we then performed 
an additional capture experiments on anti-HER2 functionalized devices using exosomes 
isolated from HER2(-) MDA-MB-231cell lines and observed a negligible capture levels 
(blue; Figure S5c, Supporting Information). This is possibly due to the lack of HER2 
expression in MDA-MB-231cell lines and cell derived exosomes. This data indicates that our 
approach is selective in capturing exosomes of interest in spiked samples, rather than any 
associated microvesicles, cell debris or protein molecules that could have possibly been 
isolated during the exosome extraction procedure.  
To assess the dynamic range and lower limit of detection (LOD) of our device, 
designated volumes of exosomes were spiked in PBS to obtain desired dilutions (1:200 to 
1:3000) and run on anti-HER2-functionalized devices under the optimal ac field strength of f 
= 1 kHz and Vpp = 100 mV.  The approximate concentration of exosomes in these samples 
was calculated from qNano measurements (see Experimental for details) and was found to 
range from 4.15 × 10
4 – 2.76 × 103  exosomes/µL. Under the applied ac-EHD field, 
colorimetric readouts (Figure 5a) and corresponding absorbance data (Figure 5b) indicate that 
the device was sensitive enough to detect samples containing approximately >2760 
exosomes/µL (i.e., 1:3000 in PBS).  The linear dynamic range of detection was found to be 
2.76 × 10
3 
(1:3000 in PBS) to 4.15 × 10
4 
exosomes/µL (i.e., 1:200 in PBS) with the lower 
limit of detection (LOD) approximately >2760 exosomes/µL. The average number of 
exosomes obtained from biological fluids (e.g., plasma, cell culture media, serum, urine etc.) 
range from 8.0 × 10
3 
 to 5.0 × 10
5 
 exosomes/µL.
23,24
  Thus, this level of detection (>2760 
exosomes/µL) indicate that our method could potentially be suitable for analysing exosomes. 
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However, we believe further optimization to the protocol and device geometry (e.g., length, 
width, and height of the channel; spacing between electrodes in the long array of asymmetric 
pairs) could further improve the capture performance of our device to meet clinically useful 
detection limits. 
We then compared the capture performance under the optimal ac-EHD flow to that of 
a hydrodynamic flow using a pressure-driven system (via a syringe pump) to drive fluid 
through the devices with the similar flow rate (7 µLmin
-1
; an equivalent to the flow generated 
under the optimal ac-EHD field of f = 1 kHz and Vpp= 100mV). Samples containing two 
different concentrations of exosomes (1:200 and 1:1000 in PBS) were driven through the 
devices under ac-EHD and pressure driven flow conditions. Figure S6a,b, Supporting 
Information, shows the capture performance of the device under ac-EHD induced fluid flow 
and pressure driven flow conditions. For both concentrations, colorimetric detection and 
corresponding absorbance data yielded a 5-fold increase in capture level and a 3-fold 
enhancement in detection sensitivity (LOD = 2750 exosomes/µL for ac-EHD vs LOD = 8300 
exosomes/µL for hydrodynamic flow; (n = 3)) under ac-EHD in comparison with pressure 
driven flow based controls. The enhanced exosome capture with the use of ac-EHD induced 
fluid flow compared to the pressure driven flow based devices may be attributed to the 
synergistic effect of the geometric arrangements of the antibody-functionalized 
microelectrode pairs within the channel, ac-EHD induced nanoshearing and concomitant 
fluid mixing phenomena.  
 To demonstrate the multiplexing capability of our device and also further examine 
the effect of nanoshearing to capture low concentration of target exosomes in large excess of 
non-target exosomes, microvesicles and cellular proteins, individual channels of the device 
was functionalized (Figure 6a) with anti-HER2 (e.g., channel-1) and anti-PSA (e.g., channel-
2) capture antibody. Target exosomes derived from a specific cell line (HER2(+) and/or 
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PSA(+)) were spiked with large excess of non-target exosomes derived from two nonspecific 
cell lines. For channel 1, specific exosomes (1:3000 in PBS) derived from BT-474 were 
spiked with two nonspecific exosomes (for both cases, 1:200 in PBS) from MDA-MB-231 
and PC3 cell lines. For channel 2, exosomes (1:3000) derived from PC3 cell line were used as 
target exosomes while exosomes (1:200) from MDA-MB-231 and BT-474 cell lines were 
used as nonspecific targets.  Figure 6a demonstrates duplex detection of spiked cell derived 
exosome samples under the applied ac field strength of f = 1 kHz and Vpp = 100 mV. It was 
clearly evident that the capture and detection performance of the device was highly 
reproducible with the device being sensitive enough to detect low concentration (1:3000) of 
target BT-474 (blue; channel-1, Figure 6a) and PC3 (green; channel-2, Figure 6a) derived 
exosomes in the presence of non-target exosomes (15 fold higher concentration than target 
exosomes). We also validated the specificity of capture by performing additional control 
experiments on anti-HER2 functionalized devices using (i) samples spiked only with non-
target exosomes derived from MDA-MB-231 and PC3 cell lines (i.e., without target BT-474 
derived exosomes) in PBS (for both cases, 1:200) and (ii) only PBS buffer (i.e., without 
target and non-target exosomes). Under the applied field strength of f = 1 kHz at Vpp = 100 
mV, a very low background response from the detection antibody (black; Figure S7, 
Supporting Information) and/or nonspecific exosomes (red; Figure S7, Supporting 
Information) was observed that further verified the high specificity of immunocapture. This 
level of background response suggests that our method is applicable to detect exosomes at 
>1:3000 concentration in the presence of 15-fold excess of nonspecific exosomes in the 
heterogeneous samples. Thus, nanoshearing can be an effective tool for the enhancement of 
target capture even at low concentrations and is comparable to the existing methodologies for 
avoiding nonspecific adsorption using molecular coatings
25
 and zwitterion complexes.
26
 
Furthermore, this detection limit and device performance is comparable with recent 
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microfluidic technologies for capture and detection of extracellular vesicles from complex 
biological samples based on immunoaffinity capture,
7
 silicon nanowires traps on 
micropillars,
8
 and nanoporous membranes
9
 that rely on size based exclusion and exosomal 
marker based immunocapture. Additionally, the key to the functionality and simplicity of our 
approach includes: (i) stimulation of fluid flow around the antibody-modified electrodes (i.e.  
fluid nanoshearing in the electrode/solution interface) improve the analysis performance of 
exosome targets via enhancing the number of sensor-target collisions as well as physically 
displacing nonspecifically adsorbed species from the electrode surface, (ii) use of a 
multiplexed device enables the analysis of multiple exosome targets isolated from complex 
biological fluids (e.g., cell culture media, serum), and (iii) on-chip naked eye detection 
coupled with absorbance measurements provides a rapid quantification tool potentially suited 
for clinical analysis of these nanovesicles.    
Finally, to investigate the diagnostic potential of our method, we performed 
experiments using HER2(+) (Patient A) and HER2(-) (Patient B) breast cancer patient serum 
(see Experimental for sample details). Individual channels of the devices were functionalized 
with anti-HER2 capture antibody and samples (500 µL for each channel) were driven through 
the devices (Patient A: channel-1; Patient B: channel-2) under optimal ac-EHD field strength 
(f = 1 kHz and Vpp = 100 mV). Colorimetric readouts (Figure 6b) suggested high capture 
levels in the HER2(+) Patient A sample whilst negligible capture levels were observed in 
HER2(-) Patient B serum. The corresponding absorbance measurements (Figure 6b) 
corroborate with these observations. The maximum absorbance (A652nm) data suggested that 
the approximate concentration of exosomes in these samples were 2× 10
4
 (Patient A) and 3.7 
× 10
3
 exosomes/μL (Patient B), respectively. Furthermore, to verify the selectivity and 
specificity of capture, these patient serum samples (500 µL) were driven through anti-CD9 
functionalized devices (Patient A: channel-1; Patient B: channel-2) under the optimal ac-
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EHD field strength (f = 1 kHz and Vpp = 100 mV). In this case, the capture performance of the 
device was found to be almost similar (Figure 6c) for both patient (HER2(+) and HER2(-)) 
serum samples. The results obtained from anti-HER2 and anti-CD9 functionalized devices 
support the fact that our approach is selective and specific in isolating exosomes rather than 
any nonspecific microvesicles, cell debris or protein molecules present in the patient samples. 
These data indicate that our approach is potentially suitable for the isolation of exosomes 
from clinical samples and can find its relevance as a simple diagnostic tool in clinical 
settings.  
 
CONCLUSIONS 
We have developed a novel microfluidic platform technology for rapid, multiplexed 
and highly specific on-chip detection and quantification of exosomes using the unique 
capacity of ac-EHD induced nanoshearing.  The versatility of our approach lies in (i) the use 
of asymmetric microelectrode pairs as fluid pumps (avoids use of additional pumps, valves, 
etc) and capture/detection domain during simultaneous capture of multiple target exosomes 
under ac-EHD induced fluid flow and (ii) the potential to be applicable for essentially any 
biochemical assay based on immunocapture (via modifying the device with any antibody 
specific to any disease biomarker). We demonstrate the ability of this approach to enhance 
the detection capabilities of the device (e.g., approximately > 2750 exosomes/µL and 5 fold 
increase in capture and detection performance in comparison to hydrodynamic fluid flow) 
and also specifically isolate exosomes from breast cancer patient samples. We envisage that 
this proof-of-concept study offering a tunable control of the target capture process and 
enabling the detection of multiple exosome targets can potentially establish its significance as 
a rapid exosome quantification tool that can find promising applications in cancer 
diagnostics.  
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FIGURE CAPTIONS 
Figure 1. Schematic representation of ac-EHD induced tunable nanoshearing for the 
specific capture of exosomes (appeared as white spherical particles). The large and 
small electrodes in an asymmetric electrode pair form the cathode and anode (or vice 
versa) of an electrolytic cell. The application of an ac field E across the electrode pairs 
results in nonuniform forces on the large and small electrodes due to the lateral 
variation in number of induced charges and their spatial distribution with the resultant 
force giving rise to unidirectional movement towards the larger electrode.  These shear 
forces generated within nanometers (λD) of an electrode surface engender fluid flow 
vortices and induce fluid mixing that can displace weakly bound nonspecific species 
and hence termed as nanoshearing. 
 
Figure 2. Schematic representation of device functionalization, exosome capture and 
colorimetric detection of captured exosomes.  
Figure 3. (a) Schematic of a multiplexed microfluidic device for exosome detection 
comprising of three independent channels. (b) Corresponding scanning electron microscopy 
(SEM) image of the enlarged segment of the device. (C) Cryo-TEM images of BT-474 cell 
derived exosomes demonstrating size and vesicular compartments such as membrane layers. 
(D) Dynamic light scattering measurements of BT-474 cell derived exosomes demonstrating 
the size range of the vesicles based on their scattered light intensity.   
Figure 4. (a) Colorimetric detection of BT-474 cell derived exosomes spiked in 500 µL PBS 
(1:200) under the frequency range f = 600 Hz- 100 kHz at Vpp = 100 mV. (b) Absorbance 
peak at 652 nm (A652nm) for exosomes spiked in PBS (1:200) under the frequency range f = 
600 Hz- 100 kHz at Vpp = 100 mV. Each data point represents the average of three separate 
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trials (n = 3) and error bars represent standard error of measurements within each experiment. 
Inset shows corresponding UV-Vis absorption spectra obtained from respective colorimetric 
solutions.  
Figure 5. (a) Colorimetric detection of samples containing spiked BT-474 cell derived 
exosomes in PBS at desired dilutions (1:200 to 1:3000) under ac-EHD field strength of                       
f = 1 kHz at Vpp = 100 mV. (b) Absorbance peak at 652 nm (A652nm) for the detected BT-474 
cell derived exosomes from spiked PBS samples at desired dilutions (1:200 to 1:3000) under 
ac-EHD field strength of f = 1 kHz at Vpp = 100 mV. Each data point represents the average 
of three separate trials (n = 3) and error bars represent standard error of measurements within 
each experiment. Inset shows corresponding UV-Vis absorption spectra obtained from 
respective colorimetric solutions.  
 
Figure 6. (a) UV-Vis absorption spectra of samples spiked with nonspecific exosomes 
derived from MDA-MB-231 (1:200) and PC3 or BT-474 (1:200) cell lines in PBS along with 
target HER2(+) BT-474 (blue; channel-1) or PSA(+) PC3 (green; channel-2) derived 
exosomes (1:3000) under the ac-EHD field strength of f = 1 kHz at Vpp = 100 mV. Inset 
shows naked eye detection of the captured BT-474 (channel-1) and PC3 (channel-2) derived 
exosomes under the applied ac-EHD field strength. (b,c) UV-Vis absorption spectra of 
HER2(+) (Patient A; red) and HER2(-) (Patient B; blue) breast cancer patient serum driven 
through (b) anti-HER2 and (c) anti-CD9 functionalized devices under the ac-EHD field 
strength of f = 1 kHz at Vpp = 100 mV. Inset shows naked eye detection of the captured 
exosomes.  
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